Letters

"Soviets Research Animals," by THOMAS J. NOVITSKY "‘No’ to Recantation," by MICHAEL STUART LOOP "Quackbusting Tales," by FREDERICK I. SCOTT JR. "Solar Booster," by A. CENGIZ BÜKER, M.C. "Islam Not Better?," by R. BHAWANI PRASAD In the spirit of glasnost, I would like to correct the statement attributed to me in the article “Perestroika Comes None Too Soon” (The Scientist, June 27, 1988, page 6), implying a universal lack of pyrogen testing (other than human

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In the spirit of glasnost, I would like to correct the statement attributed to me in the article “Perestroika Comes None Too Soon” (The Scientist, June 27, 1988, page 6), implying a universal lack of pyrogen testing (other than human) in the Soviet Union. This is definitely not the case. The story appearing in your article was related to me by a clinician from one Moscow hospital. Because research animals and test reagents were unavailable to this hospital, intravenous solution prepared in-house were tried first, after being diluted with known pyrogen-free solutions, in a limited number of elderly patients prior to being released by the pharmacy for general use. This scientifically valid approach shows a high degree of sophistication on the part of a hospital staff faced with limited resources. For all my additional contacts in the Soviet Union, I found no evidence for lack of pyrogen testing. Most manufacturers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies